← Back to Search

Behavioural Intervention

Community Mental Health Intervention for Latino Mental Health Disparities

N/A
Recruiting
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18-65
Moderate to severe clinical symptoms of anxiety, depression, and/or PTSD
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 months
Awards & highlights

Study Summary

This trial seeks to reduce mental health disparities among Latinos in the U.S. by developing and testing a culturally-appropriate intervention to improve mental health.

Who is the study for?
CRISOL Mente is for Latinos aged 18-65 living in specific counties around Philadelphia who self-identify as Latino and have moderate to severe anxiety, depression, or PTSD. It's not for those with high-risk mental health issues, current therapy participants, or pregnant individuals.Check my eligibility
What is being tested?
The trial tests CRISOL Mente, a community-based program aiming to improve access to mental health services among Latinos through outreach programs and culturally-tailored care strategies.See study design
What are the potential side effects?
Since this intervention involves non-medical community support and navigation rather than drugs or medical procedures, typical side effects associated with medications are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I experience moderate to severe symptoms of anxiety, depression, or PTSD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in mental health symptomatology (depressive, anxiety or post-traumatic stress disorder [PTSD])
Secondary outcome measures
Anxiety symptomatology
Depressive symptomatology
Post traumatic stress disorder symptomatology

Trial Design

3Treatment groups
Experimental Treatment
Group I: LHW stepped care and task shiftingExperimental Treatment3 Interventions
LHW conduct activities of prior arms but in addition, they may provide specific components of mental health care (task-shifting), providing components of basic evidence-based treatments to patients with non-complex needs, and addressing other syndemic health and social conditions.
Group II: LHW as outreach agents/navigatorsExperimental Treatment1 Intervention
Conduct outreach activities with people in the community who are hard to reach and with limited access to health care, conduct screening for symptoms of mental illnesses, encourage and refer individuals at-risk, suspected of having, or affected by mental health issues for further triage.
Group III: LHW as navigators and auxiliary to careExperimental Treatment2 Interventions
LHW continue conducting outreach and referral activities but in addition, LHW are more involved in their care. They arrange consultations, introduce the patient to the clinical team via a "warm hand-off" and assist in scheduling a follow -up visit, reviews the care plan with the patient and help reduce patient and system barriers impeding psychological well-being, support patients in achieving management goals; help patients address barriers through education, referral, and navigation to ancillary community services. They have frequent contact with the patient.

Find a Location

Who is running the clinical trial?

The Philadelphia AIDS ConsortiumUNKNOWN
Drexel UniversityLead Sponsor
150 Previous Clinical Trials
47,101 Total Patients Enrolled
Esperanza Health CenterUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are minors eligible for participation in this clinical trial?

"The age range for this clinical trial is between 18 and 65, with a minimum of adulthood being necessary to participate."

Answered by AI

What prerequisites are necessary for an individual to be eligible for this clinical trial?

"Prospective clinical trial participants should be between 18 and 65 years old, have been diagnosed with an anxiety disorder, and meet all other eligibility criteria. 600 individuals are needed for the complete study."

Answered by AI

How many participants are eligible to join this research study?

"Yes, clinicaltrials.gov updates suggest that this clinical trial is still actively seeking out participants to join. It was initially posted on November 10th 2023 and updated as recently as November 15th 2023 with a goal of recruiting 600 patients across 1 location."

Answered by AI

Are there still opportunities for people to join this scientific research effort?

"As per the latest update on clinicaltrials.gov, this medical study is still recruiting participants. It was first announced to the public on November 10th 2023 and had a subsequent edit made 5 days later."

Answered by AI

Who else is applying?

What site did they apply to?
Drexel University School of Public Health
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

Why did patients apply to this trial?

I've tried three other drug medications that did not work I'm hoping that this trial new medication will help with my condition.
PatientReceived no prior treatments
~400 spots leftby Aug 2027